Literature DB >> 8824594

Gene activation by recruitment of the RNA polymerase II holoenzyme.

S Farrell1, N Simkovich, Y Wu, A Barberis, M Ptashne.   

Abstract

The single amino acid "P" (potentiator) mutation in the holoenzyme component GAL11 creates an interaction between that protein and the dimerization region of GAL4. That interaction triggers strong gene activation when the GAL4 fragment is tethered to DNA. Here we show that, among a series of variants of the GAL4 dimerization region and different GAL11P alleles, the strength of the interaction as quantitated in vitro correlates with the degree of activation in vivo; swapping the protein fragments bearing the GAL4 dimerization region and the GAL11P mutation such that the latter is tethered to DNA and the former is attached to the holoenzyme does not diminish gene activation; gene activation in this system is squelched by overproduction of either a fragment bearing the GAL4 dimerization region or a fragment of GAL11 bearing a P mutation; and neither GAL11 nor GAL11P is a target of an acidic activating region. These results argue that the GAL4-GAL11P interaction triggers gene activation simply by recruiting the holoenzyme to DNA. Consistent with this view, we also show that fusion of LexA to another holoenzyme component, SRB2, creates an activator, and that an SRB2 mutant predicted on genetic grounds to interact especially efficiently with a holoenzyme containing a specific mutant form of polymerase also activates more efficiently when tethered to DNA.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824594     DOI: 10.1101/gad.10.18.2359

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  53 in total

1.  Transcriptional cofactor CA150 regulates RNA polymerase II elongation in a TATA-box-dependent manner.

Authors:  C Suñé; M A Garcia-Blanco
Journal:  Mol Cell Biol       Date:  1999-07       Impact factor: 4.272

2.  A bacterial two-hybrid selection system for studying protein-DNA and protein-protein interactions.

Authors:  J K Joung; E I Ramm; C O Pabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-20       Impact factor: 11.205

3.  Transcriptional activation by artificial recruitment in yeast is influenced by promoter architecture and downstream sequences.

Authors:  L Gaudreau; M Keaveney; J Nevado; Z Zaman; G O Bryant; K Struhl; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

4.  Transcriptional activation by artificial recruitment in mammalian cells.

Authors:  J Nevado; L Gaudreau; M Adam; M Ptashne
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

5.  In vivo requirement of activator-specific binding targets of mediator.

Authors:  J M Park; H S Kim; S J Han; M S Hwang; Y C Lee; Y J Kim
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  Mechanism for a transcriptional activator that works at the isomerization step.

Authors:  S L Dove; F W Huang; A Hochschild
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  RNA polymerase II and III transcription factors can stimulate DNA replication by modifying origin chromatin structures.

Authors:  M Bodmer-Glavas; K Edler; A Barberis
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

8.  RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells.

Authors:  H L Jenkins; C A Spencer
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

9.  GCN5 dependence of chromatin remodeling and transcriptional activation by the GAL4 and VP16 activation domains in budding yeast.

Authors:  G A Stafford; R H Morse
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

10.  Recruitment of the transcriptional machinery through GAL11P: structure and interactions of the GAL4 dimerization domain.

Authors:  P Hidalgo; A Z Ansari; P Schmidt; B Hare; N Simkovich; S Farrell; E J Shin; M Ptashne; G Wagner
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.